Definitive Contract 75N93020C00035
Award Date
8/14/20
Potential Completion Date
10/13/21
Potential Value
$299K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Dxdiscovery Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Reno, NV 89557, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
11
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
STTR Phase I
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Dxdiscovery Incorporated a $1,469,691 definitive contract to develop an antigen detection immunoassay for Coccidioides galactomannan under a Small Business Innovation Research Program Phase II action. As the prime contractor, Dxdiscovery Inc. will perform the work at its Reno, Nevada location over a three year period concluding on September 29, 2025. The firm...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Army Materiel Command to Dxdiscovery Inc., a for-profit Subchapter S corporation, to conduct research and development efforts. The total award amount is $999,995.10, and the contract has a firm fixed price pricing type. The contract was awarded on December 20, 2017, with a completion date of February 13, 2020. The contract is set aside for total small business participation, and the potential...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase II contract to Nowdiagnostics, Inc., a small disadvantaged business, for a multiplexed remote system for filovirus disease surveillance. The firm-fixed-price contract, with a potential value of $2,431,860.00, was awarded on September 20, 2018 and has a completion date of September 30, 2022....
<p>This federal contract award W81XWH15C0163 was issued by the U.S. Army Medical Command (MEDCOM) to Dxdiscovery Inc., a small business concern, under the Small Business Innovation Research (SBIR) program. The $149,714.90 firm-fixed-price contract is for Phase I of an SBIR project with a completion date of April 28, 2016. The contract is a definitive contract and has a total small business set-aside designation.</p>
This $243,500 firm-fixed-price purchase order was awarded to Instadiagnostics Inc., a minority-owned, for-profit small business, by the Centers for Disease Control and Prevention (CDC) under the Small Business Innovation Research (SBIR) program. The contract is for the development of rapid diagnostic tests and devices related to SBIR Topic 37. Instadiagnostics Inc. has previously received federal grants from the CDC, Department of Defense, and National Institutes of Health for the development of...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a for-profit subchapter S corporation based in Mansfield, Massachusetts. The $249,998.68 firm-fixed-price contract is for the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." Emergingdx is a company focused on developing diagnostic and biosensor technologies, with an emphasis on disease detection and precision medicine...
This federal contract award, valued at $299,659.00, was granted to Big Eye Diagnostics Inc., a small business manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Small Business Innovation Research (SBIR) program and is a Definitive Contract with a Firm Fixed Price pricing type. The contract is for the development of an "easy-to-use, low-cost triplex RDT for the...
The Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Fluid Discovery, Inc., a for-profit small business, to develop "Multiplexed Droplet Digital Nucleic Acid Amplification Technologies for HIV Diagnosis." The $299,903 firm-fixed-price contract, which runs through July 31, 2024, supports research and development of innovative...
Earlydiagnostics Inc., doing business as Earlydx, was awarded a $395,918 firm fixed price contract by the National Institutes of Health National Cancer Institute under the Small Business Innovation Research program. The contract has a total small business set aside designation. Earlydx will provide cloud-based development of a liquid-biopsy platform for the Cancer Research Data Commons, as requested in Topic 428 of the NIH/CDC SBIR solicitation seeking proposals for next generation...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Darwin Biosciences, Inc., a minority-owned, woman-owned small business based in Broomfield, Colorado. The $299,408 firm-fixed-price contract is for the development of rapid diagnostic assays to aid in the self-monitoring of acute or rebound HIV-1 infection. The contract has an ultimate completion date of April 14, 2025. As an SBIR Phase I award,...